Oramed Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Oramed Pharmaceuticals, Inc: Is Infosys Ltd. worth buying?
Item: Oramed Pharmaceuticals, Inc
Rating: 2.46050
Author: Trendlyne DVM scores

about

Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral...

4.10 0.05 (1.23%)

107.07% Gain from 52W Low

128.4K

XNAS Volume

XNAS 17 Jul, 2026 1:49 PM (EDT)

Not Eligible

Mid Valuation

46.0 / 100

Technically Neutral

52.4 / 100

1Yr Price target upside is 52%

1 analysts

Oramed Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Oramed Pharma Inc Live Stock Price Today, Share Analysis and Chart

Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral...

107.07% Gain from 52W Low

SWOT Analysis

Oramed Pharma Inc Live Price Chart

Oramed Pharma Inc Live Price Chart